[HTML][HTML] Lead Structures for Applications in Photodynamic Therapy. 6. Temoporfin Anti-Inflammatory Conjugates to Target the Tumor Microenvironment for In Vitro …

L Rogers, NN Sergeeva, E Paszko, GMF Vaz… - PLoS …, 2015 - journals.plos.org
Due to the ongoing development of clinical photodynamic therapy (PDT), the search
continues for optimized photosensitizers that can overcome some of the side effects …

Lead Structures for Applications in Photodynamic Therapy. 6. Temoporfin Anti-Inflammatory Conjugates to Target the Tumor Microenvironment for In Vitro PDT.

L Rogers, NN Sergeeva, E Paszko, GMF Vaz… - PLoS …, 2015 - search.ebscohost.com
Due to the ongoing development of clinical photodynamic therapy (PDT), the search
continues for optimized photosensitizers that can overcome some of the side effects …

Lead Structures for Applications in Photodynamic Therapy. 6. Temoporfin Anti-Inflammatory Conjugates to Target the Tumor Microenvironment for In Vitro PDT

L Rogers, NN Sergeeva, E Paszko, GMF Vaz… - PLoS …, 2015 - eprints.whiterose.ac.uk
Due to the ongoing development of clinical photodynamic therapy (PDT), the search
continues for optimized photosensitizers that can overcome some of the side effects …

[HTML][HTML] Lead Structures for Applications in Photodynamic Therapy. 6. Temoporfin Anti-Inflammatory Conjugates to Target the Tumor Microenvironment for In Vitro PDT

L Rogers, NN Sergeeva, E Paszko, GMF Vaz… - PLoS ONE, 2015 - ncbi.nlm.nih.gov
Due to the ongoing development of clinical photodynamic therapy (PDT), the search
continues for optimized photosensitizers that can overcome some of the side effects …

Lead Structures for Applications in Photodynamic Therapy. 6. Temoporfin Anti-Inflammatory Conjugates to Target the Tumor Microenvironment for In Vitro PDT

L Rogers, NN Sergeeva, E Paszko, GMF Vaz… - PloS …, 2015 - pubmed.ncbi.nlm.nih.gov
Due to the ongoing development of clinical photodynamic therapy (PDT), the search
continues for optimized photosensitizers that can overcome some of the side effects …

Lead Structures for Applications in Photodynamic Therapy. 6. Temoporfin Anti-Inflammatory Conjugates to Target the Tumor Microenvironment for In Vitro PDT

L Rogers, NN Sergeeva, E Paszko, GMF Vaz… - PLoS ONE, 2015 - go.gale.com
Due to the ongoing development of clinical photodynamic therapy (PDT), the search
continues for optimized photosensitizers that can overcome some of the side effects …

[PDF][PDF] Lead Structures for Applications in Photodynamic Therapy. 6. Temoporfin Anti-Inflammatory Conjugates to Target the Tumor Microenvironment for

L Rogers, NN Sergeeva, E Paszko, GMF Vaz… - 2015 - Citeseer
Due to the ongoing development of clinical photodynamic therapy (PDT), the search
continues for optimized photosensitizers that can overcome some of the side effects …

Lead Structures for Applications in Photodynamic Therapy. 6. Temoporfin Anti-Inflammatory Conjugates to Target the Tumor Microenvironment for In Vitro PDT.

L Rogers, NN Sergeeva, E Paszko, GM Vaz, MO Senge - Plos one, 2015 - europepmc.org
Due to the ongoing development of clinical photodynamic therapy (PDT), the search
continues for optimized photosensitizers that can overcome some of the side effects …

[PDF][PDF] Lead Structures for Applications in Photodynamic Therapy. 6. Temoporfin Anti-Inflammatory Conjugates to Target the Tumor Microenvironment for

L Rogers, NN Sergeeva, E Paszko, GMF Vaz… - 2015 - researchgate.net
Due to the ongoing development of clinical photodynamic therapy (PDT), the search
continues for optimized photosensitizers that can overcome some of the side effects …

[PDF][PDF] Lead Structures for Applications in Photodynamic Therapy. 6. Temoporfin Anti-Inflammatory Conjugates to Target the Tumor Microenvironment for

L Rogers, NN Sergeeva, E Paszko, GMF Vaz… - 2015 - core.ac.uk
Due to the ongoing development of clinical photodynamic therapy (PDT), the search
continues for optimized photosensitizers that can overcome some of the side effects …